X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Abbott India with Aurobindo Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ABBOTT INDIA vs AUROBINDO PHARMA - Comparison Results

ABBOTT INDIA     Change

Formerly known as Knoll Pharmaceuticals Limited, Abbott India Limited (AIL) is a subsidiary of Abbott Capital India Limited in which the latter holds about 69% stake. It is involved in the discovery, development, manufacture and marketing of pharmace... More

AUROBINDO PHARMA 
   Change

Aurobindo Pharma is one of India's top 5 pharma companies in terms of turnover, and has presence in the generic and Active Pharmaceutical Ingredients (API) segments. The company's robust product portfolio is spread across 6 product areas, including a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ABBOTT INDIA AUROBINDO PHARMA ABBOTT INDIA/
AUROBINDO PHARMA
 
P/E (TTM) x 40.3 14.1 285.6% View Chart
P/BV x 10.7 2.9 375.8% View Chart
Dividend Yield % 0.6 0.4 146.7%  

Financials

 ABBOTT INDIA   AUROBINDO PHARMA
EQUITY SHARE DATA
    ABBOTT INDIA
Mar-18
AUROBINDO PHARMA
Mar-18
ABBOTT INDIA/
AUROBINDO PHARMA
5-Yr Chart
Click to enlarge
High Rs6,110809 755.3%   
Low Rs3,996504 792.9%   
Sales per share (Unadj.) Rs1,552.2281.1 552.3%  
Earnings per share (Unadj.) Rs188.841.4 456.5%  
Cash flow per share (Unadj.) Rs196.450.9 386.1%  
Dividends per share (Unadj.) Rs55.002.50 2,200.0%  
Dividend yield (eoy) %1.10.4 285.8%  
Book value per share (Unadj.) Rs796.6199.4 399.6%  
Shares outstanding (eoy) m21.25585.88 3.6%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x3.32.3 139.4%   
Avg P/E ratio x26.815.9 168.6%  
P/CF ratio (eoy) x25.712.9 199.4%  
Price / Book Value ratio x6.33.3 192.6%  
Dividend payout %29.16.0 481.9%   
Avg Mkt Cap Rs m107,376384,630 27.9%   
No. of employees `0003.317.3 19.2%   
Total wages/salary Rs m3,93721,308 18.5%   
Avg. sales/employee Rs Th9,929.39,500.7 104.5%   
Avg. wages/employee Rs Th1,185.11,229.4 96.4%   
Avg. net profit/employee Rs Th1,207.71,397.9 86.4%   
INCOME DATA
Net Sales Rs m32,985164,666 20.0%  
Other income Rs m1,1701,020 114.7%   
Total revenues Rs m34,155165,686 20.6%   
Gross profit Rs m5,24537,718 13.9%  
Depreciation Rs m1625,580 2.9%   
Interest Rs m38777 4.9%   
Profit before tax Rs m6,21532,380 19.2%   
Minority Interest Rs m031 0.0%   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m2,2038,183 26.9%   
Profit after tax Rs m4,01224,229 16.6%  
Gross profit margin %15.922.9 69.4%  
Effective tax rate %35.425.3 140.3%   
Net profit margin %12.214.7 82.7%  
BALANCE SHEET DATA
Current assets Rs m22,655121,878 18.6%   
Current liabilities Rs m6,68186,806 7.7%   
Net working cap to sales %48.421.3 227.4%  
Current ratio x3.41.4 241.5%  
Inventory Days Days65130 49.9%  
Debtors Days Days2968 42.6%  
Net fixed assets Rs m83581,037 1.0%   
Share capital Rs m213586 36.3%   
"Free" reserves Rs m16,715116,218 14.4%   
Net worth Rs m16,928116,804 14.5%   
Long term debt Rs m04,512 0.0%   
Total assets Rs m24,162211,052 11.4%  
Interest coverage x163.742.7 383.7%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x1.40.8 175.0%   
Return on assets %16.811.8 141.5%  
Return on equity %23.720.7 114.3%  
Return on capital %36.927.4 135.0%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m36980,727 0.5%   
Fx outflow Rs m3,80734,700 11.0%   
Net fx Rs m-3,43846,027 -7.5%   
CASH FLOW
From Operations Rs m1,52719,548 7.8%  
From Investments Rs m-2,148-19,570 11.0%  
From Financial Activity Rs m-1,0248,642 -11.9%  
Net Cashflow Rs m-1,6468,922 -18.4%  

Share Holding

Indian Promoters % 0.0 54.1 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 7.9 8.0 99.4%  
FIIs % 0.1 27.7 0.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 17.1 10.2 167.6%  
Shareholders   18,270 69,601 26.2%  
Pledged promoter(s) holding % 0.0 8.6 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ABBOTT INDIA With:   SUN PHARMA  DR. REDDYS LAB  GSK PHARMA  FULFORD INDIA  PROCTER & GAMBLE HEALTH  

Compare ABBOTT INDIA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 318 Points Lower; Auto and Metal Stocks Witness Selling(Closing)

India share markets continued to witness selling pressure during closing hours and ended their day on a negative note.

Related Views on News

AUROBINDO PHARMA Announces Quarterly Results (4QFY19); Net Profit Up 10.9% (Quarterly Result Update)

May 30, 2019 | Updated on May 30, 2019

For the quarter ended March 2019, AUROBINDO PHARMA has posted a net profit of Rs 6 bn (up 10.9% YoY). Sales on the other hand came in at Rs 53 bn (up 30.7% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (4QFY19); Net Profit Up 13.1% (Quarterly Result Update)

May 28, 2019 | Updated on May 28, 2019

For the quarter ended March 2019, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 13.1% YoY). Sales on the other hand came in at Rs 9 bn (up 15.0% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

AUROBINDO PHARMA Announces Quarterly Results (3QFY19); Net Profit Up 19.3% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, AUROBINDO PHARMA has posted a net profit of Rs 7 bn (up 19.3% YoY). Sales on the other hand came in at Rs 53 bn (up 21.5% YoY). Read on for a complete analysis of AUROBINDO PHARMA's quarterly results.

ABBOTT INDIA Announces Quarterly Results (3QFY19); Net Profit Up 1.4% (Quarterly Result Update)

Feb 12, 2019 | Updated on Feb 12, 2019

For the quarter ended December 2018, ABBOTT INDIA has posted a net profit of Rs 1 bn (up 1.4% YoY). Sales on the other hand came in at Rs 9 bn (up 7.5% YoY). Read on for a complete analysis of ABBOTT INDIA's quarterly results.

AUROBINDO PHARMA 2017-18 Annual Report Analysis (Annual Result Update)

Dec 19, 2018 | Updated on Dec 19, 2018

Here's an analysis of the annual report of AUROBINDO PHARMA for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of AUROBINDO PHARMA. Also includes updates on the valuation of AUROBINDO PHARMA.

More Views on News

Most Popular

These 3 Smallcap Stocks are Set to Make the Most of Smallcap Rebound(Profit Hunter)

Jul 9, 2019

As the sense of normalcy returns to the markets, the rebound in the quality smallcaps could be huge.

2 Stocks from Super Investor Sanjay Bakshi's Portfolio You Can Bet On...(The 5 Minute Wrapup)

Jul 12, 2019

Despite the current fear prevailing in the markets, both these stocks have the potential to deliver in 4-5 years.

After Disappointing Budget, Here's a Document that Concerns Largecap and Smallcap Investors(The 5 Minute Wrapup)

Jul 8, 2019

A new 'definition' of the stock universe that triggered the smallcap sell-off is back with the latest list...

Union Budget 2019-2020: More Style Over Substance(The 5 Minute Wrapup)

Jul 5, 2019

Did the Union Budget announce measures to stimulate the economy and bolster corporate earnings growth?

Here's What to Do with Falling Small Cap Stocks(Profit Hunter)

Jul 10, 2019

There are some great buying opportunities in the market right now - and the small cap space is your best bet.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

ABBOTT INDIA SHARE PRICE


Jul 18, 2019 (Close)

TRACK ABBOTT INDIA

  • Track your investment in ABBOTT INDIA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ABBOTT INDIA - PLETHICO PHARMA COMPARISON

COMPARE ABBOTT INDIA WITH

MARKET STATS